Nicolas Leupin Novo Cure LTD (NVCR) insider trading activity
Nicolas Leupin is Chief Medical Officer of NovoCure Ltd. Currently has a direct ownership of 51,124 shares of NVCR, which is worth approximately $1.64 Million. The most recent transaction as insider was on Feb 27, 2024, when has been sold 51,124 shares (Ordinary Shares) at a price of $16.3 per share, resulting in proceeds of $833,321. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
51.1K
0%
3M change
n/a
12M change
Total Value Held
$1.64 Million
NL
Nicolas Leupin
Chief Medical Officer
Wayne, PA